Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Oncology|August 5, 2022
Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal LymphomaJunxiang Gu, Tingting Jiang, Shixue Liu, et al.
American Journal of Ophthalmology|March 24, 2023
Longitudinal Analysis of Ocular Manifestation and Interleukin During Intravitreal Treatment of Vitreoretinal Lymphoma With MethotrexateJunxiang Gu, Tingting Jiang, Shixue Liu, et al.
Ophthalmology. Retina|November 2, 2023
Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal LymphomaShixue Liu, Tingting Jiang, Junxiang Gu, et al.
RMD Open|June 9, 2021
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)Stanley B Cohen, Janet Pope, Boulos Haraoui, et al.
Ophthalmology. Retina|October 11, 2023
Characteristics of Vitreoretinal Lymphoma in B-Scan Ultrasonography: A Case-Control StudyJunxiang Gu, Qian Chen, Peijun Zhang, et al.
Discover Oncology|May 11, 2025
Tumour-infiltrating immune cells as a novel prognostic model for bladder cancerCan Liu, Chaoyu Liao, Bishao Sun, et al.
The Lancet. Rheumatology|January 17, 2024
Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trialStanley B Cohen, Janet Pope, Boulos Haraoui, et al.
RMD Open|January 31, 2023
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled studyXiaomei Leng, Wei Lin, Shixue Liu, et al.
Retina (Philadelphia, Pa.)|November 16, 2023
ASSOCIATION OF TESSELLATION DENSITY WITH PROGRESSION OF AXIAL LENGTH AND REFRACTION IN CHILDREN: An Artificial Intelligence-Assisted 4-Year StudyRuoyan Wei, Jun Li, Weiming Yang, et al.
Annals of the Rheumatic Diseases|June 7, 2024
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension studyHermine I Brunner, Jonathan D Akikusa, Eslam Al-Abadi, et al.
Pageof 3